| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/18/2006 | US20060106048 Furoisoquinoline derivative and use thereof |
| 05/18/2006 | US20060106046 2-(3,4-difluorophenyl)-N-methyl-2-(1H-1,2,3-triazol-1-yl)-N-[3-(spiro[isobenzofuran-1(3H), 4'-piperidin]-1-yl)propyl]acetamide, used for preventing or treating cardiovascular, nervous, metabolic, reproductive, respiratory and/or digestive system disorders |
| 05/18/2006 | US20060106037 Purin-6-one-derivatives |
| 05/18/2006 | US20060105987 Sulfur-containing phospholipid derivatives |
| 05/18/2006 | US20060105957 Loop peptide and TGFalpha for stimulating stem cell proliferation and migration |
| 05/18/2006 | US20060105946 Method for treating the central nervous system by administration of igf structural analogs |
| 05/18/2006 | US20060105378 Tenascin-C nucleic acid ligands |
| 05/18/2006 | US20060104964 Recombinant sequence, its preparation and use |
| 05/18/2006 | US20060104963 Use of transfected stem cell population expressing an antiangiogenic fragment of human tryptophanyl tRNA synthetase (TrpRS); cell-based gene therapy |
| 05/18/2006 | US20060104942 Anticholesterol agents; anticholesterol agents; cardiovascular disorders; mixture of colony stimulating factor and hepatocyte growth factor |
| 05/18/2006 | CA2591474A1 Therapeutic or preventive agents for ischemic heart disease or ischemic cardiomyopathy |
| 05/18/2006 | CA2587444A1 Guanidine derivatives as inhibitors of ddah |
| 05/18/2006 | CA2587188A1 Pharmaceutical preparation for the treatment of friedreich's ataxia |
| 05/18/2006 | CA2586918A1 Use of ion channel modulating compounds for treating acute atrial fibrillation in a human |
| 05/18/2006 | CA2586840A1 Use of ranolazine in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure |
| 05/18/2006 | CA2586106A1 Sulfamides as endothelin receptor antagonists for the treatment of cardiovascular diseases |
| 05/18/2006 | CA2585165A1 Dual antiplatelet/anticoagulant pyridoxine analogs |
| 05/17/2006 | EP1657242A1 Imidazopyridine derivatives |
| 05/17/2006 | EP1657233A1 Lipoxin compounds |
| 05/17/2006 | EP1656952A2 Polymer conjugates of interferon beta-1A and uses thereof |
| 05/17/2006 | EP1656945A1 Pharmaceutical composition comprising oligoarginine |
| 05/17/2006 | EP1656941A1 Compositions for the treatment of diabetic nephropathy |
| 05/17/2006 | EP1656940A1 Angiotensin II receptor antagonists for treating vascular headache conditions |
| 05/17/2006 | EP1656936A1 Macrophage activation inhibitor |
| 05/17/2006 | EP1656368A2 Substituted hertocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 05/17/2006 | EP1656154A1 Pharmaceutical composition comprising plant material of trichilia sp. alone or in association with other plant extracts for the reversion/combat and/or prevention of ventricular fibrilation |
| 05/17/2006 | EP1656137A1 Channel blocking compounds |
| 05/17/2006 | EP1656134A1 Indoline-sulfanilic acid amides used as ppar delta modulators |
| 05/17/2006 | EP1656123A2 Anti-candida agents for the treatment of prion diseases |
| 05/17/2006 | EP1558252A4 Substituted furo 2,3-b| pyridine derivatives |
| 05/17/2006 | EP1543003B1 Imidazo¬1,2-a|pyridines |
| 05/17/2006 | EP1423391B1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 05/17/2006 | EP1362047B1 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 05/17/2006 | EP1349864B1 Cyclic salen-metal compounds as scavengers for oxygen radicals and useful as antioxidants in the treatment and prevention of diseases |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1280555B1 Pharmaceutical composition comprising furosemide and conivaptan for the treatment of congestive heart failure |
| 05/17/2006 | EP1274711B1 New aza-indolyl derivatives |
| 05/17/2006 | EP1272220B1 Formulation for the prevention of cardiovascular disease |
| 05/17/2006 | EP1265616B1 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate |
| 05/17/2006 | EP1214409B1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 05/17/2006 | EP1204652B1 Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 05/17/2006 | EP1140881B1 Antithrombotic amides |
| 05/17/2006 | EP1114035B1 Quinazoline derivatives and pharmaceutical applications thereof |
| 05/17/2006 | EP1109914B1 Heme oxygenase 1 for the inhibition of smooth muscle cell migration |
| 05/17/2006 | EP1109787B1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 05/17/2006 | EP0990024B1 Use of lactobacillus for reduction of the fibrinogen level in blood |
| 05/17/2006 | CN1774635A Anti-epileptogenic agents |
| 05/17/2006 | CN1774444A Novel derivatives of androstane and androstene with ascorbic acid and use thereof in treating or preventing various conditions, diseases, and disorders |
| 05/17/2006 | CN1774443A Phosphates of secondary alcohols |
| 05/17/2006 | CN1774429A Medicinal composition |
| 05/17/2006 | CN1774428A M-stage kinesin inhibitor |
| 05/17/2006 | CN1774245A Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 05/17/2006 | CN1774243A Therapeutic compositions |
| 05/17/2006 | CN1772761A Serial cyclovirobuxine compounds as new medicine for preventing and treating cardiac vascular diseases and their prepn |
| 05/17/2006 | CN1772751A Substituted oxazolidinones and their use in the field of blood coagulation |
| 05/17/2006 | CN1772301A Nimodipine soft capsule and its prepn |
| 05/17/2006 | CN1772281A Chinese herbal medicine decoction for treating cold-wetness type thromboangitis obliterans and its prepn |
| 05/17/2006 | CN1772237A Quality control method for pile eliminating tablet |
| 05/17/2006 | CN1772229A Chinese herbal medicine decoction for treating virulent heat-evil type thrombotic angeitis and its prepn |
| 05/17/2006 | CN1772228A Recipe of pile quick healing ointment |
| 05/17/2006 | CN1772220A Chinese herbal medicine decoction for treating endogenous wind type hemiplegia and its prepn |
| 05/17/2006 | CN1772208A Chinese medicine composition for preventing and treating hypertension, hyperlipemia and hyperglycemia |
| 05/17/2006 | CN1772200A Chinese medicine for treating cerebral arteriosclerosis and its prepn |
| 05/17/2006 | CN1772196A Heart failure regulating Chinese medicine |
| 05/17/2006 | CN1772175A Hypertension treating medicated wine |
| 05/17/2006 | CN1772170A Glabrous greenbrier total saponin extract and its prepn and use |
| 05/17/2006 | CN1772155A Chinese herbal medicine decoction for treating vital energy stagnation and blood stasis type thrombotic angeitis and its prepn |
| 05/17/2006 | CN1772149A Chinese medicine composition for treating coronary heart disease and its prepn |
| 05/17/2006 | CN1772133A Hypertension treating capsule |
| 05/17/2006 | CN1772132A Health wine and its prepn process |
| 05/17/2006 | CN1772125A Medicine for treating piles and its prepn |
| 05/17/2006 | CN1772121A Wild camellia seed oil soft capsule |
| 05/17/2006 | CN1772119A Medicine for treating coronary heart disease and angina pectoris and its prepn |
| 05/17/2006 | CN1772103A Chinese herbal medicine decoction for treating blood deficiency low fever and its prepn |
| 05/17/2006 | CN1772096A Arrhythmia treating Chinese medicine composition |
| 05/17/2006 | CN1772082A Pile treating medicine |
| 05/17/2006 | CN1772078A Hypertension treating medicine |
| 05/17/2006 | CN1772071A Compound notoginseng composition for treating cardiac and cerebral vascular diseases |
| 05/17/2006 | CN1772070A Diketone composition for treating cardiac and cerebral vascular diseases |
| 05/17/2006 | CN1772069A Medicine for treating ischemic cerebral disease and its prepn |
| 05/17/2006 | CN1772063A Inner pile treating orally taken medicine |
| 05/17/2006 | CN1772059A Medicine for treating cerebral infarction, coronary heart disease and angina pectoris |
| 05/17/2006 | CN1772057A Pile treating Chinese medicine |
| 05/17/2006 | CN1772052A Chinese medicine composition for treating cerebral hemorrhage and its prepn |
| 05/17/2006 | CN1772041A Quality detection method for compound prepn of red sage and notoginseng |
| 05/17/2006 | CN1772023A Refined angelica oil and its extraction process and prepn form |
| 05/17/2006 | CN1772020A Freeze dried pubescent holly powder for injection and its prepn |
| 05/17/2006 | CN1772018A Quality control method for speedwell flavone capsule |
| 05/17/2006 | CN1772017A Application of speedwell extract in preparing medicine |
| 05/17/2006 | CN1772016A Medicine prepn for treating cerebral apoplexy and its prepn |
| 05/17/2006 | CN1772014A Application of yacon leaf extract |
| 05/17/2006 | CN1772013A Quality control method for ginkgo-dipyridamine injection |
| 05/17/2006 | CN1772012A Freeze dried ginkgo leaf powder for injection and its prepn |
| 05/17/2006 | CN1772011A Ginkgo leaf extract composition and its prepn |
| 05/17/2006 | CN1772010A Ginkgo leaf extract capsule composition and its prepn |